Cross Country Valuation
| XXY Stock | EUR 10.10 0.10 0.98% |
At this time, the firm appears to be overvalued. Cross Country Healthcare shows a prevailing Real Value of €9.55 per share. The current price of the firm is €10.1. Our model approximates the value of Cross Country Healthcare from analyzing the firm fundamentals such as Return On Equity of 0.5, profit margin of 0.07 %, and Current Valuation of 1.18 B as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Cross Country's price fluctuation is somewhat reliable at this time. Calculation of the real value of Cross Country Healthcare is based on 3 months time horizon. Increasing Cross Country's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cross stock is determined by what a typical buyer is willing to pay for full or partial control of Cross Country Healthcare. Since Cross Country is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cross Stock. However, Cross Country's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.1 | Real 9.55 | Hype 10.2 |
The real value of Cross Stock, also known as its intrinsic value, is the underlying worth of Cross Country Healthcare Company, which is reflected in its stock price. It is based on Cross Country's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cross Country's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Cross Country Healthcare helps investors to forecast how Cross stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cross Country more accurately as focusing exclusively on Cross Country's fundamentals will not take into account other important factors: Cross Country Total Value Analysis
Cross Country Healthcare is at this time estimated to have takeover price of 1.18 B with market capitalization of 925.43 M, debt of 148.74 M, and cash on hands of 24.83 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Cross Country fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.18 B | 925.43 M | 148.74 M | 24.83 M |
Cross Country Investor Information
About 100.0% of the company outstanding shares are owned by institutional investors. The book value of Cross Country was at this time reported as 12.6. The company has Price/Earnings To Growth (PEG) ratio of 0.96. Cross Country Healthcare recorded earning per share (EPS) of 5.67. The entity had not issued any dividends in recent years. Based on the key measurements obtained from Cross Country's financial statements, Cross Country Healthcare is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Cross Country Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cross Country has an asset utilization ratio of 296.11 percent. This implies that the Company is making €2.96 for each dollar of assets. An increasing asset utilization means that Cross Country Healthcare is more efficient with each dollar of assets it utilizes for everyday operations.Cross Country Ownership Allocation
Cross Country holds a total of 36.82 Million outstanding shares. The majority of Cross Country Healthcare outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Cross Country Healthcare to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Cross Country. Please pay attention to any change in the institutional holdings of Cross Country Healthcare as this could imply that something significant has changed or is about to change at the company. Also note that nearly one million nine hundred twenty-two thousand twenty invesors are currently shorting Cross Country expressing very little confidence in its future performance.Cross Country Profitability Analysis
The company reported the revenue of 2.81 B. Net Income was 188.46 M with profit before overhead, payroll, taxes, and interest of 627.69 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cross Country's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cross Country and how it compares across the competition.
About Cross Country Valuation
The stock valuation mechanism determines Cross Country's current worth on a weekly basis. Our valuation model uses a comparative analysis of Cross Country. We calculate exposure to Cross Country's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cross Country's related companies.Cross Country Healthcare, Inc. provides healthcare staffing, recruiting, and workforce solutions in the United States. Cross Country Healthcare, Inc. was founded in 1996 and is headquartered in Boca Raton, Florida. CROSS COUNT operates under Staffing Outsourcing Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1750 people.
8 Steps to conduct Cross Country's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Cross Country's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Cross Country's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Cross Country's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Cross Country's revenue streams: Identify Cross Country's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Cross Country's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Cross Country's growth potential: Evaluate Cross Country's management, business model, and growth potential.
- Determine Cross Country's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Cross Country's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Cross Stock analysis
When running Cross Country's price analysis, check to measure Cross Country's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cross Country is operating at the current time. Most of Cross Country's value examination focuses on studying past and present price action to predict the probability of Cross Country's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cross Country's price. Additionally, you may evaluate how the addition of Cross Country to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |